how many people are on glp 1 drugs GLP-1 Market Size to Hit USD 132.79 Bn by 2035 Addressing GLP-1 Access and Adherence

Supply shortages have plagued tirzepatide since its approval

Research continues to explore the broader therapeutic potential of GLP-1, including its effects on the cardiovascular system, brain function, and its potential role in the treatment of conditions beyond type 2 diabetes, such as Parkinson's disease and Alzheimer's disease

nested ophthalmic analysis of the RCT (exenatide) was the only study to conduct formal neuropsychological testing for cognitive function assessment, whereas OLeary et al

Research consistently shows that increasing protein intake to 1.2-1.6g per kilogram of body weight enhances weight loss outcomes regardless of the primary intervention

[DOI] [PubMed] [Google Scholar] 9

Step 2: The insurance company will review the prior authorization request to determine if it's valid